Svetlana Dey insider trades: Bluejay Diagnostics (BJDX) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Svetlana reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 13, 2023 | BJDX | ↑ Buy | 500 | $3.07 | $2K | Direct | Dec 14, 2023 (1d) |
| Mar 17, 2022 | BJDX | ↑ Buy | 10,000 | $1.18 | $12K | Direct | Mar 21, 2022 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Svetlana Dey's insider trades
Svetlana Dey is a director at Bluejay Diagnostics (BJDX). Since Mar 17, 2022, Svetlana has reported 2 open-market purchases worth $13K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BJDX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.